Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Photograph by Sandra Smiley Photograph by Sandra Smiley
Press release
Press release |
20 October 2017
Intellectual property and trade
JapanASEAN

RCEP negotiations should not restrict global access to affordable medicines and vaccines

Mothers with young children wait for consultation at the MåSF mobile clinic in Pusuguppa, which is a small village in AP along with border of Chhattisgarh. MSF mobile clinic provides free primary health care services which include diagnostic tests, vaccination, malaria and tuberculosis treatment, antenatal and postnatal consultations. Photograph by Sami Siva Photograph by Sami Siva
Press release
Press release |
13 October 2017
Vaccines
India

MSF approaches Delhi High Court to challenge unmerited patent grant for pneumonia vaccine

Malawi. June 30, 2017. Patrick Chipungu, 51 years, an MSF clinician looks at Simbazako Thove's X-Ray. Simbazako is 19 years and HIV and TB positive. Photograph by Luca Sola
Press release
Press release |
13 October 2017
Tuberculosis

People still being denied improved treatment for multidrug-resistant TB

4 min
Kissing bugs (known as "vinchucas" in Bolivia and other Latin American countries) are usually found in houses in rural areas. These houses are made of adobe, a mixture of clay and straw. Photograph by Juan Renau Photograph by Juan Renau

v

Press release
Press release |
31 August 2017
Tropical & neglected diseases

Chagas drug will be available in US

5 min
Zhare Dasht' (Yellow Desert). Measles vaccination. Photograph by Sebastian Bolesch Photograph by Sebastian Bolesch
Press release
Press release |
28 August 2017
Vaccines
Iraq

MSF takes next steps to lower vaccine prices: Launch of innovative tool to help countries negotiate lower pneumonia vaccine prices

MSF staff taking care of a child after he has been vaccinated. Photograph by Pierre-Yves Bernard Photograph by Pierre-Yves Bernard
Press release
Press release |
22 August 2017
Intellectual property and trade Vaccines
India

Indian patent office delivers major blow to affordable pneumonia vaccine hopes

7 min
South Africa: Patient groups welcome release of Draft Intellectual Property Policy Photograph by Stefan Heunis
Press release
Press release |
14 August 2017
Intellectual property and trade
South Africa

South Africa: Patient groups welcome release of Draft Intellectual Property Policy

Drug-resistant patient showing daily drug dose Photograph by Sami Siva
Press release
Press release |
03 August 2017
Intellectual property and trade Research and development

Congress fails to boost treatment for neglected diseases

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury